Patent: 6,303,155
✉ Email this page to a colleague
Summary for Patent: 6,303,155
Title: | Treatment of conditions associated with impairment in the level of the parathyroid hormone |
Abstract: | A method for restoration of the circadian rhythm of parathyroid hormone (PTH) serum levels in a subject having osteoporosis, so as to restore a circadian rhythm of PTH levels which is similar to that existing in normal subjects is disclosed by administering a single daily dose of a composition consisting essentially of an effective amount of phosphate in the evening or at night, whereby the composition causes a circadian rhythm of PTH levels which peaks during the night, whereby the circadian rhythm of PTH levels is restored to that which is similar to that existing in normal subjects, thereby treating osteoporosis. |
Inventor(s): | Silver; Justin (Motza Illit, IL) |
Assignee: | Hadasit Medical Research Services and Development Company, Ltd. (Jerusalem, IL) |
Application Number: | 09/258,907 |
Patent Claims: | see list of patent claims |
Details for Patent 6,303,155
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2016-02-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |